tirzepatide vs semaglutide for weight loss and key differences, results (2026) Tirzepatide vs. Semaglutide for Weight

At 72 weeks, those in the tirzepatide group had a significant reduction in body weight of 18.4% compared with a 2.5% increase with placebo

Long-term use of semaglutide may even lower the risk of major cardiovascular events like heart attacks, particularly in patients with type 2 diabetes

Troy Watson at Set Point Medical Weight Loss Clinic offers GLP-1 therapy, which includes Tirzepatide, to support weight loss through appetite regulation and improved insulin sensitivity

doi: 10.1016/j.ejphar.2017.07.015 31 StevenSHausdingMKrller-SchnSMaderMMikhedYStammPet al

In rodents, Botfield and colleagues [103] demonstrated that exendin-4 administration reduced intracranial pressure in hydrocephalic female rats